Eyedrops applied to glaucoma of mid-aged people and aged people and preparation method
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology for glaucoma and eye drops, applied in the field of medicine used by glaucoma patients
Inactive Publication Date: 2016-10-12
王金国
View PDF2 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0005] 2. The vision is gradually declining, and the vision correction of optometry is less than 1.0 (logarithmic visual acuity chart is 5.0), especially for people with hig
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0059] Ingredients: 30 parts of Shijue Ming, 3 parts of antelope horns, 6 parts of rhubarb, 15 parts of Rehmannia glutinosa, 10 parts of tangerine peel, 18 parts of Bupleurum, 12 parts of moxibustion licorice, 15 parts of platycodon, 3 parts of travoprost, breviscapine 10 parts, 2 parts musk, 1 part borneol.
[0060] preparation:
[0061] 1) Weigh each raw material: 30 parts of Shijue Ming, 3 parts of antelope horns, 6 parts of rhubarb, 15 parts of Rehmannia glutinosa, 10 parts of tangerine peel, 18 parts of Bupleurum, 12 parts of moxibustion and licorice, 15 parts of Platycodon grandiflorum, Travo Front 3 parts of vegetarian, 10 parts of breviscapine, 2 parts of musk, 1 part of borneol;
[0062] 2) Wash and dry the above raw materials, cassia cassia, antelope horn, rhubarb, rehmannia glutinosa, tangerine peel, Bupleurum, moxibustion licorice, platycodon, Erigeron breviscapus, clean and dry, smash into particles, smash to 120 mesh, and mix the crushed powder evenly spare;
[0063] 3...
Embodiment 2
[0076] Ingredients: 45 parts of Shijue Ming, 8 parts of antelope horn, 10 parts of Rhubarb, 20 parts of Rehmannia glutinosa, 15 parts of tangerine peel, 22 parts of Bupleurum, 20 parts of moxibustion licorice, 15 parts of platycodon, 5 parts of travoprost, breviscapine 15 parts, 4 parts musk, 2 parts borneol.
[0077] The preparation method and use method are the same as in Example 1.
Embodiment 3
[0079] Ingredients: 20 parts of Shijue Ming, 5 parts of antelope horns, 6 parts of rhubarb, 12 parts of Rehmannia glutinosa, 8 parts of tangerine peel, 15 parts of Bupleurum, 12 parts of moxibustion licorice, 8 parts of platycodon, 3 parts of travoprost, breviscapine 8 parts, 1 part musk, 1 part borneol.
[0080] The preparation method and use method are the same as in Example 1.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses eyedrops applied to mid-aged people and aged people and a preparation method. The eyedrops are prepared from the following raw materials in parts by weight: 20-50 parts of concha haliotidis, 2-8 parts of cornu saigae tataricae, 5-10 parts of Chinese rhubarb, 10-20 parts of unprocessed rehmannia roots, 6-15 parts of dried orange peel, 15-25 parts of radix bupleuri, 12-20 parts of processed licorice roots, 6-15 parts of platycodon roots, 2-5 parts of travoprost eye drops, 6-15 parts of erigeron breviscapus, 1-5 parts of musk and 1-2 parts of borneol. The eyedrops suitable for being used for the glaucoma of mid-aged people and aged people are prepared through scientific compatibility, and are used for treating a common frequent eye disease namely senile glaucoma which is caused by that intraocular pressure rises relatively (low intraocular pressure glaucoma) or absolutely (high intraocular pressure glaucoma) due to discording viscera, dislocation of fluid and long accumulation of pathological products in eyes, and which has main clinical situations that people suffer from diseases of swelling pain of eyes, being dim-sighted during looking at things, diminution of vision, even dizziness, headaches, nausea, vomit and the like.
Description
Technical field [0001] The invention relates to medicines used by glaucoma patients, and specifically provides an eye drops applied to middle-aged and elderly glaucoma and a preparation method thereof. Background technique [0002] Middle-aged and elderly glaucoma is a common ophthalmological disease in the elderly. It is a disease of visual papillary perfusion caused by elevated intraocular pressure, complicated by visual dysfunction. As the incidence of primary glaucoma increases with age, it is divided into angle-closure and open-angle glaucoma (that is, anterior chamber angle occlusion or sclerosis and degeneration of trabecular meshwork, reduced function and weakened ciliary muscles affect the function of trabecular meshwork, resulting in humor drainage disorder Increased intraocular pressure) two types. Senile glaucoma includes acute glaucoma and chronic glaucoma. Acute angle-closure glaucoma has acute onset, severe eye pain, rapid decline in vision, nausea, vomiting, and...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more